Can routine laboratory tests discriminate SARS‐CoV‐2‐infected pneumonia from other causes of community‐acquired pneumonia?

Abstract

Abstract Background The clinical presentation of SARS‐CoV‐2‐infected pneumonia (COVID‐19) resembles that of other etiologies of community‐acquired pneumonia (CAP). We aimed to identify clinical laboratory features to distinguish COVID‐19 from CAP. Methods We compared the hematological and biochemical features of 84 patients with COVID‐19 at hospital admission and 221 patients with CAP. Parameters independently predictive of COVID‐19 were calculated by multivariate logistic regression. The receiver operating characteristic (ROC) curves were generated and the area under the ROC curve (AUC) was measured to evaluate the discriminative ability. Results Most hematological and biochemical indexes of patients with COVID‐19 were significantly different from patients with CAP. Nine laboratory parameters were identified to be predictive of a diagnosis of COVID‐19. The AUCs demonstrated good discriminatory ability for red cell distribution width (RDW) with an AUC of 0.87 and hemoglobin with an AUC of 0.81. Red blood cell, albumin, eosinophil, hematocrit, alkaline phosphatase, and mean platelet volume had fair discriminatory ability. Combinations of any two parameters performed better than did the RDW alone. Conclusions Routine laboratory examinations may be helpful for the diagnosis of COVID‐19. Application of laboratory tests may help to optimize the use of isolation rooms for patients when they present with unexplained febrile respiratory illnesses.

Keywords

• 2019 novel coronavirus
• community‐acquired pneumonia
• COVID‐19
• routine laboratory tests
• SARS‐CoV‐2